Cash conversion remains robust with an OCF/NI ratio of 2.83 in 2026Q1, though management has prioritized aggressive capital deployment through $293.9 million in quarterly buybacks as recently as 2025Q2.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Cash from Operations | 571.23M | 581.78M | 628.3M | 91.27M | 679.81M | 1.41B | 892.18M | 363.47M | 311.04M | 288.45M | 350.62M | 287.1M | 281.6M | 158.59M | 152.17M | 224.87M | 164.25M | 148.72M | 217.84M | 205.13M | 127.44M | 208.09M | 200.76M | 167.47M | 101.5M | 123.3M | 145.55M | 115.8M | 69.6M | 34.8M | 80.2M |
| Operating CF Margin % | - | 20.37% | 22.81% | 3.32% | 20.53% | 36.86% | 23.59% | 12.6% | 11.2% | 12.78% | 16.57% | 13.64% | 12.59% | 7.32% | 7.19% | 11.7% | 9.64% | 9.59% | 11.11% | 11.48% | 8.24% | 14.12% | 14.05% | 10.91% | 6.74% | 9.27% | 8.59% | 8.5% | 4.94% | 2.38% | 5.62% |
| Operating CF Growth % | -26.64% | -7.4% | 588.38% | -86.57% | -51.81% | 58.12% | 145.46% | 16.86% | 7.83% | -17.73% | 22.12% | 1.95% | 77.56% | 4.22% | -32.33% | 36.91% | 10.44% | -31.73% | 6.2% | 60.96% | -38.76% | 3.65% | 19.87% | 64.99% | -17.68% | -15.29% | 25.69% | 66.38% | 100% | -56.61% | -46.6% |
| Net Income | 240.96M | 241.2M | 283.07M | 179.5M | 512.68M | 889.44M | 630.56M | 227.75M | 237.47M | 156.89M | 215.71M | 188.78M | 130.14M | 174.27M | 71.29M | 1.17M | 138.91M | 74.33M | 127.77M | 131.69M | 119.58M | 66.53M | 75.88M | 52.96M | -151.94M | 34.51M | 90.52M | 154.3M | 102M | 33.7M | 60.2M |
| Depreciation & Amortization | 412.97M | 405.34M | 427.85M | 431.77M | 427M | 311.44M | 201.65M | 214.03M | 180.59M | 105M | 99.97M | 105.36M | 110.47M | 126.88M | 125.13M | 110.92M | 89.16M | 80.76M | 88.61M | 80.83M | 69.48M | 124.38M | 75.7M | 89.78M | 96.11M | 84.26M | 87.72M | 66.1M | 48.5M | 42.7M | 40.9M |
| Stock-Based Compensation | 23.83M | 22.85M | 37.81M | 41.41M | 51.52M | 29.68M | 26.9M | 31.51M | 28.77M | 25.42M | 17.16M | 17.28M | 14.06M | 14.05M | 20.63M | 15.48M | 12.42M | 13.99M | 19.34M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | -61.48M | -61.48M | -110.31M | -97.48M | -107.41M | -53.4M | -30.82M | -61.78M | -51.77M | 29.04M | -6.82M | -11.91M | -40.96M | -64.36M | -64.17M | 5.19M | -32.17M | 27.5M | -12.07M | -21.82M | -10.01M | 1.42M | 21.93M | -11.84M | -35.37M | 0 | 0 | 0 | 11.3M | 0 | 0 |
| Other Non-Cash Items | 58.16M | 70.65M | 8.18M | -72.58M | 58.99M | 100.61M | 215.21M | 116.61M | 46.71M | 9.77M | 59.63M | 52.53M | 128.17M | 22.36M | 143.22M | 82.84M | -4.08M | 43.12M | 4.02M | 5.92M | 9.79M | 11.43M | 28.87M | 14.17M | 143.59M | 39.46M | -5.78M | -87.4M | -114.4M | 15.8M | -400K |
| Working Capital Changes | -103.2M | -96.78M | -18.3M | -391.35M | -262.97M | 132.99M | -151.32M | -164.66M | -130.73M | -37.66M | -35.03M | -64.94M | -60.28M | -114.6M | -143.92M | 9.27M | -39.99M | -90.98M | -9.83M | 8.51M | -61.4M | 4.33M | -1.63M | 22.4M | 49.11M | -34.93M | -26.91M | -17.2M | 22.2M | -57.4M | -20.5M |
| Change in Receivables | -57.62M | -101.02M | -15.97M | -9M | 66.09M | 165.59M | -398.85M | -100.63M | -94.51M | -36.63M | -18.96M | 4.06M | -12.06M | -14.07M | -44.88M | -20.6M | -38.1M | -30.44M | -11.69M | -29.65M | 3.31M | -10.43M | 17.95M | 43.36M | 35.28M | 13.97M | -4.26M | -54.4M | 7.8M | -24.5M | -11.8M |
| Change in Inventory | 7.43M | 14.78M | 45.09M | -14.11M | -48.63M | 32.28M | -127.36M | -9.61M | -30.18M | -17.92M | 6.75M | -27.93M | -19.44M | -14.17M | -7.86M | -2.2M | -22.54M | -4.47M | -10.17M | 341K | -11.07M | -323K | 5.63M | 28.16M | 48.23M | -39.5M | -23.38M | 12.1M | 3.3M | -2.5M | -6.7M |
| Change in Payables | -15.25M | 7.34M | -26.02M | -76.43M | -43.8M | -7.58M | 63.23M | 7.35M | 8.9M | 34.33M | 30.72M | -10.9M | 2.85M | -1.08M | -8.08M | -1.78M | 27.79M | -10.44M | 4.82M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -89.25M | -17.35M | 776.16M | 1.31B | -132.85M | -4.11B | -504.5M | -487.57M | -159.86M | -1.27B | -83.88M | -100.86M | -295.9M | -1.21M | -80.31M | -909.86M | 295.15M | -153.87M | -135.68M | -349.34M | -139.5M | 323.29M | -11.68M | 177.23M | -156.04M | 66.52M | -401.43M | -143.9M | -46.5M | 1.9M | -71.3M |
| Capital Expenditures | -77.31M | -73.52M | -86.65M | -81.37M | -85.63M | -86.02M | -63.63M | -81.33M | -93.25M | -39.09M | -31.7M | -28.22M | -27.15M | -38.98M | -42.4M | -30.59M | -33.65M | -25.52M | -43.33M | -46.98M | -44.47M | -25.05M | -15.82M | -17.55M | -67.82M | -88.7M | -70.6M | -343.4M | -262.4M | -51.3M | -80.5M |
| CapEx % of Revenue | 2.66% | 2.57% | 3.15% | 2.96% | 2.59% | 2.25% | 1.68% | 2.82% | 3.36% | 1.73% | 1.5% | 1.34% | 1.21% | 1.8% | 2% | 1.59% | 1.97% | 1.65% | 2.21% | 2.63% | 2.88% | 1.7% | 1.11% | 1.14% | 4.51% | 6.67% | 4.16% | 25.19% | 18.64% | 3.51% | 5.64% |
| Acquisitions | -67.28M | 0 | 0 | -1.93M | 6.99M | -3.98B | -407.21M | -399.86M | -59.66M | -1.53B | -50.92M | -72.04M | -271.48M | -15.7M | -40.86M | -914.04M | -150.37M | -101.93M | -90.66M | -315.87M | -133.13M | -17.57M | 2.77M | 534K | -22.51M | 45.46M | -397.38M | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 56.11M | 56.55M | 156.9M | 2.07B | -15.91M | -22.96M | -13.59M | 0 | 72K | 272.82M | -1.26M | -598K | 2.73M | 53.47M | 2.95M | 34.77M | 479.17M | -26.43M | -1.7M | 13.51M | 14.48M | 365.91M | 1.37M | 194.24M | -65.71M | 109.76M | 87.01M | 193.4M | 208.3M | 49.1M | -200K |
| Cash from Financing | -782.75M | -855.05M | -1.13B | -947.12M | -661.8M | 2.94B | -202.87M | 150.13M | -179.23M | 782.24M | -115.01M | -107.14M | 30.93M | -154.16M | -44.16M | 397.2M | -218.37M | 2.41M | -101.08M | 148.89M | -313.51M | -217.85M | -195.94M | -298.35M | 30.67M | -170.33M | 259.79M | 62M | 14M | -22.7M | -36.5M |
| Debt Issued (Net) | -471K | -521K | -723.07M | -517.49M | -559.17M | 3.04B | -187.47M | 208.87M | -66.04M | 822.16M | 63.09M | -35.07M | 106.33M | -16.84M | -35.58M | 518.56M | -141M | 44.83M | -9.52M | 359.03M | -110.75M | -166.7M | -174.96M | -262.17M | 68.67M | -177M | 251.01M | 59.5M | 52.4M | 24.5M | 16M |
| Equity Issued (Net) | -747.98M | -817.89M | -369.58M | -388.88M | -66.52M | -47.95M | 30.73M | -6.31M | -57.45M | -3.83M | -151.8M | -76.44M | -65.53M | -127.4M | -2.1M | -110M | -72.77M | -8.38M | -31.77M | -170.59M | -168.6M | -5.01M | 15.04M | 3.62M | 13.13M | 37.69M | 36.31M | 27.9M | -12.9M | -21.4M | -26M |
| Dividends Paid | -32.21M | -32.8M | -34.45M | -34.97M | -35.34M | -32.37M | -31.21M | -31.06M | -31.01M | -30.79M | -30.8M | -31.57M | -31.62M | -31.6M | -31.9M | -31.83M | -32.99M | -32.7M | -33.07M | -33.7M | -35.45M | -36.3M | -35.78M | -35.41M | -35.28M | -28.29M | -27.53M | -25.5M | -25.4M | -25.7M | -26.6M |
| Share Repurchases | -753.72M | -820.82M | -369.58M | -388.88M | -80.64M | -73.07M | -6.94M | -6.31M | -57.45M | -3.83M | -151.8M | -76.44M | -65.53M | -127.4M | -2.1M | -110M | -72.77M | -14.62M | -75.51M | -202.97M | -190.12M | -24.4M | 0 | 0 | -5.92M | -1.78M | -10.59M | -1M | -41.2M | -28.1M | -30.8M |
| Other Financing | -2.09M | -3.84M | -1.13M | -5.79M | -767K | -21M | -14.92M | -21.37M | -24.73M | -5.29M | 4.5M | 35.94M | 21.75M | 21.68M | 25.42M | 20.48M | 28.39M | -1.34M | -26.72M | -5.85M | 1.3M | -9.85M | -237K | -4.38M | -15.84M | -2.73M | 0 | 100K | -100K | -100K | 100K |
| Net Change in Cash | -277.94M | -244.59M | 250.08M | 443.63M | -148.59M | 216.72M | 210.72M | 25.58M | -36.05M | -157.13M | 121.33M | 63.11M | 1.58M | 1.8M | 29.1M | -277.74M | 240.38M | 597K | -24.24M | 12.29M | -311.2M | 304.75M | 6.01M | 60.88M | -7.63M | 13.97M | -1.1M | 31.1M | 37.6M | 10M | -28.3M |
| Free Cash Flow | 504.75M | 508.25M | 541.65M | 9.9M | 594.18M | 1.32B | 828.54M | 282.14M | 217.78M | 249.36M | 318.91M | 257.47M | 252.53M | 119.6M | 109.76M | 194.28M | 130.61M | 117.04M | 174.52M | 158.15M | 82.97M | 183.04M | 181.8M | 149.93M | 33.69M | 34.6M | 74.95M | -227.6M | -194.9M | -13.9M | -300K |
| FCF Margin % | 17.39% | 17.8% | 19.66% | 0.36% | 17.94% | 34.61% | 21.9% | 9.78% | 7.84% | 11.05% | 15.07% | 12.23% | 11.29% | 5.52% | 5.19% | 10.11% | 7.66% | 7.55% | 8.9% | 8.85% | 5.37% | 12.42% | 12.72% | 9.77% | 2.24% | 2.6% | 4.42% | -16.7% | -13.84% | -0.95% | -0.02% |
| FCF Growth % | -3.69% | -6.17% | 5369.01% | -98.33% | -55.15% | 59.89% | 193.67% | 29.55% | -12.66% | -21.81% | 23.87% | 1.96% | 111.14% | 8.96% | -43.5% | 48.75% | 11.6% | -32.94% | 10.35% | 90.62% | -54.67% | 0.69% | 21.26% | 345.09% | -2.64% | -53.84% | 132.93% | -16.78% | -1302.16% | -4533.33% | -100.34% |
| FCF per Share | 4.51 | 4.49 | 4.41 | 0.08 | 4.70 | 11.35 | 7.39 | 2.53 | 1.95 | 2.25 | 2.89 | 2.27 | 2.22 | 1.05 | 0.96 | 1.71 | 1.11 | 1.00 | 1.47 | 1.31 | 0.66 | 1.39 | 1.40 | 1.16 | 0.27 | 0.32 | 0.74 | -2.49 | -2.12 | -0.15 | -0.00 |
| FCF Conversion (FCF/Net Income) | 2.09x | 2.41x | 2.12x | -0.77x | 1.19x | 1.50x | 1.23x | 1.60x | 1.30x | 2.55x | 1.50x | 1.35x | 1.78x | 0.94x | 2.22x | 191.87x | 0.43x | 1.74x | 1.70x | 1.54x | 1.09x | 2.55x | 2.65x | 3.16x | -24.55x | -198.87x | 1.61x | 4.08x | 0.68x | 1.03x | 1.33x |
| Interest Paid | 0 | 0 | 91.09M | 94.01M | 97.93M | 54.12M | 42.14M | 82.69M | 56.45M | 35.78M | 30.72M | 31.74M | 30.32M | 39.9M | 40.45M | 12.18M | 12.23M | 12.41M | 20.16M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 154.88M | 359.8M | 323.08M | 364.56M | 162.45M | 77.06M | 59.84M | 77.61M | 43.55M | 49.27M | 40.64M | 36.67M | 53.28M | 41.64M | 32.91M | 35.38M | 38.36M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Newborn screening volume sensitivity
As reported in recent financial filings, Revvity consistently generates operating cash flow significantly higher than net income, with the OCF/NI ratio reaching 2.83 in 2026Q1, suggesting that non-cash charges and accounting adjustments play a disproportionate role in the company's reported bottom-line profitability metrics.
The persistent gap between net income and operating cash flow indicates that reported earnings are heavily influenced by substantial depreciation and amortization expenses, likely tied to the integration of recent acquisitions. Investors should monitor whether this divergence reflects genuine operational efficiency or simply the accounting treatment of intangible assets following the company's portfolio transformation.
Based on the provided cash flow data, Revvity's free cash flow margin has fluctuated between 14.9% and 24.8% over the last ten quarters, indicating that while the company remains cash-generative, its ability to convert revenue into free cash flow remains sensitive to ongoing restructuring and integration costs.
The variability in FCF margins suggests that the company's cash generation profile is still stabilizing post-divestiture. While the business maintains a consistent ability to produce cash, the lack of a clear upward trajectory in FCF margins warrants further investigation into whether current cost structures are fully optimized for the new pure-play model.
According to historical cash flow statements, Revvity maintains a disciplined capital expenditure profile, with CapEx/Revenue ratios consistently hovering between 2.4% and 3.5%, suggesting that the company's core diagnostic and life science operations do not require heavy, recurring reinvestment to maintain their current installed base.
This low capital intensity is a positive indicator for long-term cash flow sustainability, as it allows a greater portion of operating cash flow to be directed toward debt reduction or shareholder returns. The stability of these expenditures implies that the company's primary growth drivers are likely driven by reagent pull-through and software rather than massive infrastructure expansion.
Data from recent quarterly reports reveals significant swings in working capital, ranging from a $82.8 million inflow in 2023Q4 to a $48.9 million outflow in 2025Q2, highlighting the inherent difficulty in managing inventory and receivables during the company's ongoing organizational and portfolio realignment.
These fluctuations suggest that Revvity's cash conversion cycle is susceptible to timing differences in product shipments and collections, which may be exacerbated by the transition to new business segments. Investors should monitor these working capital movements closely, as they represent a primary source of quarterly cash flow volatility that can obscure underlying operational performance.
As evidenced by the cash flow statements, Revvity has prioritized share repurchases over other forms of capital deployment, with quarterly buybacks reaching as high as $293.9 million in 2025Q2, signaling a management focus on returning capital to shareholders despite the ongoing costs of portfolio integration.
The scale of these repurchases relative to free cash flow suggests a high degree of confidence in the company's long-term valuation, though it also limits the cash available for organic R&D or strategic bolt-on acquisitions. This capital allocation strategy warrants further investigation to ensure that the company is not sacrificing necessary growth investments for short-term earnings per share support.
Quick answers to the most common questions about buying RVTY stock.
Revvity, Inc. (RVTY) generated $581.8M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
Revvity, Inc. (RVTY) generated $508.3M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
Revvity, Inc. (RVTY) spent $73.5M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2025, Revvity, Inc. (RVTY) returned $32.8M to shareholders via cash dividends and spent $820.8M on share repurchases. This shows the company's commitment to returning capital to its equity investors.